Drug
Gadopiclenol clinical trials
Also written P03277 and Elucirem.
- studies test it
- 17
- open now
- 5
- in phase 3
- 5
- first study started
- 2013
Keep track of what changes. Save the gadopiclenol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2025 (3)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 4
- Phase 3
- 5
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 6
Guerbet (11) · University of California, San Diego (1) · M.D. Anderson Cancer Center (1) · UConn Health (1) · Johns Hopkins University (1) · Columbia University (1) · Insel Gruppe AG, University Hospital Bern (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gadopiclenol is read from its arms, and is right about nine times in ten.
Testing it · 17
- Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular DiseaseRecruitingPhase 3GuerbetNCT07348640Written as gadopiclenol
- Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal DiseaseRecruitingNot applicableM.D. Anderson Cancer CenterNCT07415018Written as VUEWAY
- Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)RecruitingPhase 4UConn HealthNCT06846853Written as Gadopiclenol
- High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar AssessmentRecruitingPhase 4Johns Hopkins UniversityNCT05954559Written as Elucirem (Gadopiclenol)
- Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and HemodynamicsNot yet recruitingPhase 3University of California, San DiegoNCT06406517Written as Gadopiclenol
- Randomized Comparison of Contrast Agents Gadopiclenol and Gadobutrol in the Workup of Incidental Renal and Adrenal FindingsTerminatedPhase 4Insel Gruppe AG, University Hospital BernNCT07040865Written as Gadopiclenol
- Gadopiclenol in Contrast Enhanced MRI of the ProstateSuspendedPhase 4Columbia UniversityNCT06226129Written as Gadopiclenol
- Performance of Elucirem in DSC-MRI Perfusion of Brain GliomasCompletedPhase 3GuerbetNCT06057168Written as Elucirem
- Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of AgeCompletedPhase 2GuerbetNCT05590884Written as Gadopiclenol
- Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)CompletedPhase 3GuerbetNCT03986138Written as gadopiclenol
- Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)CompletedPhase 3GuerbetNCT03996447Written as gadopiclenol
- Cardiac Safety Evaluation of P03277CompletedPhase 1GuerbetNCT03657264Written as P03277 0.1 mmol/kg
- Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRICompletedPhase 2GuerbetNCT03749252Written as P03277
- P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)CompletedPhase 2GuerbetNCT02633501Written as P03277
- Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy VolunteersCompletedPhase 1GuerbetNCT04906005Written as gadopiclenol
- Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain LesionsCompletedPhase 1/2GuerbetNCT03603106Written as P03277
- Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal FunctionCompletedPhase 1GuerbetNCT03657784Written as P03277
Given in every arm · 1 — gadopiclenol is usual care beside what is tested
Codes
What other systems call gadopiclenol · ClinicalTrials.gg INT001252
- MeSH (NLM) C000656634gadopiclenolConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) S276568KOYGADOPICLENOLConfirmed FDA, NLM, Wikidata
- RxNorm 2618720One source FDA
- Wikidata Q114748523gadopiclenolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C128640GadopiclenolOne source FDA
- DrugBank DB17084One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000656634 | gadopiclenol | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | S276568KOY | GADOPICLENOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2618720 | — | One source FDA |
| Wikidata | Q114748523 | gadopiclenol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C128640 | Gadopiclenol | One source FDA |
| DrugBank | DB17084 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.